| Mepha Pharma AG - Co-Lisinopril-Mepha 20 mg/12.5 mg, Tabletten |
| 56856 | | 02 | | Co-Lisinopril-Mepha 20 mg/12.5 mg | | Tabletten | | C09BA03 | | Lisinopril und Diuretika | | 20.08.2004 | | |
|
| Composition |
| lisinoprilum 20 mg ut lisinoprilum dihydricum, hydrochlorothiazidum 12.5 mg, mannitolum, calcii hydrogenophosphas dihydricus, amylum pregelificatum, carmellosum natricum conexum corresp. natrium 0.756 mg, magnesii stearas, pro compresso. |
| Packungsbestandteile |
| Comprimés | | | | | Principe actif | Concentr. |
|---|
| Hydrochlorothiazide | 12.5 mg | | Lisinopril | 20 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Hydrochlorothiazide | 12.5 mg | | Lisinopril | 20 mg |
| | | | Agents auxilliaires |
|---|
| Amylum Pregelificatum | | Calcium Hydrogenophosphate Dihydrate | | Carmellosum Natricum Conexum | | Magnesii Stearas | | Mannitol | | Pro Compresso |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 003 | 30 Comprimé(s) | 7.80 | 24.90 | B | LS | Non | | 004 | 100 Comprimé(s) | 25.60 | 44.25 | B | LS | Non |
|
